Victor Sandor
Vermögen: 150 534 $ am 30.06.2026
Vermögen: 150 534 $ am 30.06.2026
Dr. Victor Sandor, MD, is an Independent Director at AbCellera Biologics, Inc., an Independent Director at Kymera Therapeutics, Inc., an Independent Director at Prelude Therapeutics, Inc. and an Independent Non-Executive Director at ADC Therapeutics SA. He is on the Board of Directors at AbCellera Biologics, Inc., Kymera Therapeutics, Inc., Prelude Therapeutics, Inc., ADC Therapeutics SA and Istari Oncology, Inc. Dr. Sandor was previously employed as an Independent Non-Executive Director by Merus NV, a Chief Medical Officer by Array BioPharma, Inc., a Chief Medical Officer-Oncology & VP by Biogen Idec, Inc. (North Carolina), a Senior VP-Drug Development by Incyte Corp., and a Head-Oncology Product Development by AstraZeneca, Inc. He received his doctorate degree from McGill University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 0,11 % | 03.06.2026 | 140.686 ( 0,11 % ) | 150 534 $ | 30.06.2026 |
| 09.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 | |
| 24.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ADC THERAPEUTICS SA | Direktor/Vorstandsmitglied | 27.04.2020 |
| PRELUDE THERAPEUTICS INCORPORATED | Direktor/Vorstandsmitglied | 01.05.2020 |
| KYMERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.11.2022 |
| ABCELLERA BIOLOGICS INC. | Direktor/Vorstandsmitglied | 01.06.2026 |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Direktor/Vorstandsmitglied | 01.07.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| MERUS N.V. | Direktor/Vorstandsmitglied | 12.12.2025 |
| INCYTE CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 |
| ARRAY TECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01.09.2014 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
AbCellera Biologics, Inc.
AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Prelude Therapeutics, Inc.
Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen